“My main innovation is the development of nanotechnology and microfloidic chips that are capable of identifying tumor cells in blood samples.” The key application of this technology is the diagnosis of circulating tumor cells that helps physicians diagnose cancer in the early stages and better monitor the treatment process.
He added: “This technology provides personalized medical opportunity, so that medications and treatments are designed for each person specifically and appropriate to their condition.”
“The ultimate goal of this new method is to provide accurate treatments at the right time and with the right diagnosis, so that all medications are designed and prescribed for each patient in particular,” said Mustafa’s chosen scientist.
He said: “My course began with a field of mechanical engineering at MIT University. Then I entered the Harvard Medical School through a joint program between MIT and Harvard. I was always interested in surgery before and wished to get a surgeon.
(tagstotranslate) Mustafa Award (T) Scientific Research (T) Personal Medicine
Latest Passing over countries : Spain | Dominica | United Arab Emirates
RCO NEWS
